Nanoveu (ASX: NVU) – Inside Look at EMASS IP Strategy
Dr. Aly reveals that Nanoveu holds exclusive rights to 7 licensed IPs covering hardware, software, and system-level design—developed by the EMASS inventor himself, now leading R&D at NVU.
New patents are in the pipeline, aimed at automating AI workflows and enabling tiny language models on edge devices.
Protection already secured across the US, Singapore, and China.